An assessment of the impact of thimerosal on childhood neurodevelopmental disorders
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The prevalence of autism in the US has risen from 1 in approximately 2500 in the mid-1980s to 1 in approximately 300 children in the mid-1990s. The purpose of this study was to evaluate whether mercury from thimerosal in childhood vaccines contributed to neurodevelopmental disorders. Neurodevelopmental disorder dose-response curves for increasing mercury doses of thimerosal in childhood vaccines were determined based upon examination of the Vaccine Adverse Events Reporting System (VAERS) database and the 2001 US' Department of Education Report. The instantaneous dosage of mercury children received in comparison to the Food and Drug Administration (FDA)'s maximum permissible dose for the oral ingestion of methylmercury was also determined. The dose-response curves showed increases in odds ratios of neurodevelopmental disorders from both the VAERS and US Department of Education data closely linearly correlated with increasing doses of mercury from thimerosal-containing childhood vaccines and that for overall odds ratios statistical significance was achieved. Similar slopes and linear regression coefficients for autism odds ratios in VAERS and the US Department of Education data help to mutually validate each other. Controls employed in the VAERS and US Department of Education data showed minimal biases. The evidence presented here shows that the occurrence of neurodevelopmental disorders following thimerosal-containing childhood vaccines does not appear to be coincidental.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of Autism in a US Metropolitan Area
Yeargin-Allsopp, M., Rice, C., Karapurkar, T., Doernberg, N., Boyle, C., & Murphy, C. (2003) · JAMA · doi:10.1001/jama.289.1.49 · Cited by 1,248 · cited 1×
“In addition, recent studies have analysed the prevalence of autism from the mid-1980s through the mid1990s and determined that the prevalence of autism has risen from one in 2500 children in the mid-1980s to one in 300 children in 1996 [10–12].”
The UCLA-University of Utah epidemiologic survey of autism: prevalence
(1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.2.194 · Cited by 273
Cited by
Toxic Effects of Mercury on the Cardiovascular and Central Nervous Systems
Fernandes Azevedo, B., Barros Furieri, L., Peçanha, F. M., Wiggers, G. A., Frizera Vassallo, P., Ronacher Simões, M., Fiorim, J., Rossi de Batista, P., Fioresi, M., Rossoni, L., et al. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/949048 · Cited by 455
Windham, G. C., Zhang, L., Gunier, R., Croen, L. A., & Grether, J. K. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.9120 · Cited by 424
“Thimerosal has been removed from routine pediatric vaccines, but public debate and animal research continue (Burbacher et al. 2005; Geier and Geier 2003).”
BackgroundFombonne, E., Zakarian, R., Bennett, A., Meng, L., & McLean-Heywood, D. (2006) · Pediatrics · doi:10.1542/peds.2005-2993 · Cited by 399
Kalkbrenner, A. E., Schmidt, R. J., & Penlesky, A. C. (2014) · Current Problems in Pediatric and Adolescent Health Care · doi:10.1016/j.cppeds.2014.06.001 · Cited by 268
Mercury Exposure and Public Health
Clifton, J. C. (2007) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2007.02.005 · Cited by 252
Metadata
- Authors
- Geier, D. A., & Geier, M. R.
- Venue
- Pediatric Rehabilitation
- Publisher
- Informa UK Limited
- Published
- 2003-01
- Volume
- 6
- Issue
- 2
- Pages
- 97-102
- ISSN
- 1363-8491 (ISSN-L)
- OpenAlex
- W2132045182
- Cited by
- 86
- References
- 2
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An assessment of the impact of thimerosal on childhood neurodevelopmental disorders. https://app.cochat.ai/papers/10.1080/1363849031000139315
- The paper
- Geier, D. A., & Geier, M. R. (2003). An assessment of the impact of thimerosal on childhood neurodevelopmental disorders. Pediatric Rehabilitation. https://doi.org/10.1080/1363849031000139315
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.